Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effect of Race and Insurance Status on Treatment and Outcomes in Diabetic Retinopathy: Analysis of 43 274 Eyes Using the IRIS Registry

Journal of VitreoRetinal Diseases(2024)10.1177/24741264231221607Source: DataRank Database

Effect of Race and Insurance Status on Treatment and Outcomes in Diabetic Retinopathy: Analysis of 43 274 Eyes Using the IRIS Registry is a dataset published in Journal of VitreoRetinal Diseases (2024). On theSindex it has a DataRank of 0.561, placing it in the top 34.9% of the data-sharing corpus. It has been cited 9 times, with 7 citing works in its 1-hop citation network.

Top 35%percentile

0.561DataRank

Ranks in the top 35% for downstream scientific impact

Data paper Open Access9 citations · 7 citing works in its network

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 3.52)OA: greenTopics (20)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (1/3)

Dataset classification

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 62%Citation Network 38%

Base Score Contribution

0.345

From this paper's citation signal

Citation Network Contribution

0.216

From 3 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 7 citers.

What Factors Lead to Disparities in Healthcare and Healthcare Providers and What Should Be Done to Address Them?
Journal of VitreoRetinal Diseases20242 citations6 referencesContributes 0.183
Association between insurance status and prevalence of diabetic retinopathy in patients with diabetes in the United States from 2011 to 2020
Primary care diabetes20242 citations24 referencesContributes 0.046
Association of the Social Deprivation Index With the Severity and Treatment of Diabetic Retinopathy
Journal of VitreoRetinal Diseases20261 citations28 referencesContributes 0.025
Racial and Ethnic Disparities at Enrollment in DRCRnet Clinical Trials for Diabetic Macular Edema
American Journal of Ophthalmology20250 citations25 referencesContributes 0.000
Big data in ophthalmology: comparative databases and research applications
Current Opinion in Ophthalmology20250 citations61 referencesContributes 0.000

Authors (6)

Vikas Maturi,Adrienne W. Scott ORCID,Kathryn A. Carson ORCID,Thomas A. Ciulla ORCID,Raj K. Maturi ORCID

Live enrichment

PubMed:38770080 PMC:PMC11102718 OpenAlex:https://openalex.org/W4390587543

NCATS NIH HHS

Grant: UL1 TR003098

2019 Hoskins Grant

FWCI

3.52

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: https://journals.sagepub.com/page/policies/text-and-data-mining-license

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11102718/pdf/10.1177_24741264231221607.pdf

publisherhttps://journals.sagepub.com/doi/pdf/10.1177/24741264231221607

publisherhttps://journals.sagepub.com/doi/full-xml/10.1177/24741264231221607

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11102718

Fields of Study

Retinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Optic Conditions

Keywords

Race (biology)Diabetic retinopathyIRIS (biosensor)MedicineOptometryOphthalmologyDiabetes mellitusArtificial intelligenceComputer scienceBiometricsSociologyGender studiesEndocrinologyRACEInsuranceAntivascular Endothelial Growth FactorHealth Equity

sj-xlsx-1-vrd-10.1177_24741264231221607 – Supplemental material for Effect of Race and Insurance Status on Treatment and Outcomes in Diabetic Retinopathy: Analysis of 43 274 Eyes Using the IRIS Registry

10.25384/sage.24945285SAGE Journals

sj-jpeg-3-vrd-10.1177_24741264231221607 – Supplemental material for Effect of Race and Insurance Status on Treatment and Outcomes in Diabetic Retinopathy: Analysis of 43 274 Eyes Using the IRIS Registry

10.25384/sage.24945282SAGE Journals

sj-jpeg-2-vrd-10.1177_24741264231221607 – Supplemental material for Effect of Race and Insurance Status on Treatment and Outcomes in Diabetic Retinopathy: Analysis of 43 274 Eyes Using the IRIS Registry

10.25384/sage.24945279SAGE Journals

10.25384/sage.24945279.v1SAGE Journals

10.25384/sage.24945282.v1SAGE Journals

10.25384/sage.24945285.v1SAGE Journals

Related Papers (1)

Trends in Research Payments for Diabetic Macular Edema from 2015 to 2021

Top 42%

0.444DataRank

Ophthalmology Science(2023)

co-cited

10.1016/j.xops.2023.100379